SCHEMBL19543715

SCHEMBL19543715

c1ccc(-c2cnc(-c3cc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)cc(-c4cc5ccccc5c5ccccc45)c3)nc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.53
▸ RAB9A P51151 5/20 0.53
▸ SMN1; SMN2 Q16637 4/20 0.53
▸ NFKB1 P19838 2/20 0.53
▸ NFKB2 Q00653 2/20 0.53
▸ RELA Q04206 2/20 0.53
▸ CYP11B1 P15538 1/20 0.49
▸ MAPT P10636 3/20 0.45
▸ LMNA P02545 1/20 0.45
▸ RECQL P46063 1/20 0.45
▸ HPGDS O60760 9/20 0.41
▸ KDM4E B2RXH2 3/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ TP53 P04637 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ MPI P34949 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31369124 0.89 CYP11B1 (0.51) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL18533197 0.89 CYP11B1 (0.51) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL18878261 0.89 CYP11B1 (0.51) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL17932319 0.89 CYP11B1 (0.51) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL9958660 0.89 CYP11B1 (0.54) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL17932326 0.88 CYP11B1 (0.51) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL17932472 0.88 CYP11B1 (0.43) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL23065684 0.88 CYP11B1 (0.50) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL9957253 0.87 CYP11B1 (0.48) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL22512511 0.86 CYP11B1 (0.49) NPC1RAB9ASMN1; SMN2NFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11329230-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2022-05-10 — — US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 — — US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11329230-B2 Organic light-emitting device EML4, SUN2, TRPA1 NPC1 317/4885RAB9A 1433/4885SMN1; SMN2 4133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback